Kings Point Capital Management’s Vaxart VXRT Stock Holding History

Kings Point Capital Management’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,904	Closed	-$12K	–	659
2021 Q4	$12K	Sell	1,904 -4,096	-68%	-$28K	﹤0.01%	617
2021 Q3	$48K	Hold	6,000	–	–	﹤0.01%	364
2021 Q2	$45K	Hold	6,000	–	–	﹤0.01%	359
2021 Q1	$36K	Sell	6,000 -1,000	-14%	-$7.69K	﹤0.01%	378
2020 Q4	$40K	Hold	7,000	–	–	﹤0.01%	340
2020 Q3	$47K	Sell	7,000 -945	-12%	-$8.42K	0.01%	319
2020 Q2	$70K	Sell	7,945 -1,145	-13%	-$3.29K	0.01%	246
2020 Q1	$16K	Buy	+9,090	New	+$11.6K	﹤0.01%	401

Other funds holding VXRT

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Kings Point Capital Management's VXRT Position: Q1 2022 in Review

Kings Point Capital Management sold out of Vaxart (VXRT) in Q1 2022, closing a stake of 1,904 shares — an estimated $12K sold.

Kings Point Capital Management first reported a position in VXRT in Q1 2020 and held it in 8 quarters. The position peaked at $70K in Q2 2020. 148 funds tracked by Wall St. Rank hold VXRT as of Q1 2022.

Kings Point Capital Management reported no remaining Vaxart position as of Q1 2022 after selling out during the quarter.
Kings Point Capital Management sold 1,904 Vaxart shares in Q1 2022, an estimated $12K.
Kings Point Capital Management first reported a position in Vaxart in Q1 2020 and held it in 8 quarters.
Kings Point Capital Management's Vaxart position peaked at $70K in Q2 2020.
148 funds tracked by Wall St. Rank held Vaxart as of Q1 2022.

Based on Kings Point Capital Management's 13F filing for Q1 2022, filed 13 May 2022.